Skip to main content
U.S. flag

An official website of the United States government

Research News

2022

  • Early HIV

    Early HIV Diagnosis and Treatment Important for Better Long-term Health Outcomes

    October 21 — Starting antiretroviral treatment (ART) early in the course of HIV infection when the immune system is stronger results in better long-term health outcomes compared with delaying ART, according to findings presented today at the IDWeek Conference in Washington, D.C. The findings are based on an extended follow-up of participants in the National Institutes of Health-funded Strategic Timing of Antiretroviral Treatment (START) study.

    • New
  • Hepatitis B

    Three-dose Hepatitis B Vaccine Regimen Protects People with HIV

    October 20 — A three-dose course of the hepatitis B vaccine HEPLISAV-B fully protected adults living with HIV who had never been vaccinated against or infected with the hepatitis B virus (HBV), according to study findings presented today at the IDWeek conference in Washington, D.C. The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, sponsors the ongoing Phase 3 ACTG A5379 clinical study.

    • New
  • NEWS

    NIH Announces Additional Funding Awards for Ending the HIV Epidemic Initiative Implementation Research Projects

    October 6, 2022 — Last month, as part of their support of the Ending the HIV Epidemic in the U.S. (EHE) initiative, NIH announced 66 awards to institutions participating in the NIH-funded Centers for AIDS Research (CFAR) and the NIMH AIDS Research Centers (ARC) programs. This was the fourth year of NIH investments in EHE-focused research projects. These new awards total $26 million and will support research in 33 of the EHE priority jurisdictions to strengthen research-community collaborations and enhance the implementation science knowledge base needed to end the HIV epidemic.

    • New
  • NEWS

    White House Publishes Federal Implementation Plan for National HIV/AIDS Strategy

    August 26, 2022 — The National HIV/AIDS Strategy (NHAS) Federal Implementation Plan reflects the collaborative work of representatives from 10 federal departments and details more than 380 action items they will implement individually and collaboratively. This plan documents federal agencies’ commitments to programs, policies, research, and other activities needed to meet the NHAS goals. These critical activities, which encompass work to for fiscal years 2022–2025, will move our indicators of progress in the right directions.

  • Gears of Government Awards - President's Award

    New Insights into HIV Latent Cells Yield Potential Cure Targets

    July 27, 2022 — In a presentation today at AIDS 2022, the 24th International AIDS Conference in Montreal, scientists with the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center (VRC) and their collaborators described how their use of cutting-edge technology revealed new insights into cellular reservoirs of HIV and what those observations could mean for the next steps in HIV cure research. NIAID is part of the National Institutes of Health.

  • HIV Infected T-cell

    Finding HIV’s ‘Sweet Spot’

    July 22, 2022 — An NIH-funded team has found that patterns of sugars at the surface of our own human immune cells affect their vulnerability to HIV infection.

  • Scanning electron micrograph of an HIV-infected H9 T cell, colorized in Halloween colors

    In people with HIV, treating precancerous anal lesions cuts risk of anal cancer by more than half

    June 15, 2022 — Nearly all cases of anal cancer are caused by infection with cancer-causing types of HPV.

  • NEWS

    Creating a one-stop shop for HIV research

    June 9, 2022 — access issue of the Journal of Acquired Immunodeficiency Syndrome (JAIDS) will highlight HIV implementation science findings, reported by scientists and implementations teams funded by the National Institutes of Health through the Ending the HIV Epidemic initiative. (JAIDS)

  • NEWS

    How Lessons From HIV Research Informed COVID-19 Vaccine Trials

    May 12, 2022 — A new study shows how community engagement approaches developed by the HIV Vaccine Trials Network strengthened COVID-19 vaccine trials.

  • NEWS

    Transactional sex, HIV and health among young cisgender men and transgender women who have sex with men in Thailand

    April 8, 2022 — Study examines how recent sex work is identified and the HIV risk factors and service needs among Thai cisgender men who have sex with men and transgender women who exchange sex. (Elsevier: Annals of Epidemiology)

  • Scanning electron micrograph of an HIV-infected H9 T cell, colorized in Halloween colors

    NIH launches clinical trial of three mRNA HIV vaccines

    March 14, 2022 — Phase 1 study is among first to examine mRNA technology for HIV.

  • Scanning electron micrograph of an HIV-infected H9 T cell, colorized in Halloween colors

    Researchers document third known case of HIV remission involving stem cell transplant

    February 15, 2022 — Woman has remained without detectable HIV for 14 months

  • NEWS

    First HIV Vaccines Administered in Moderna Clinical Trial

    January 2022 – Moderna announces the launch of human clinical trials for an experimental HIV vaccine that uses the same kind of mRNA technology found in Moderna’s COVID-19 vaccine. (The Hill)

This page last reviewed on October 28, 2022